Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Future Oncology (London, England)|January 28, 2020
Safety of antiemetic prophylaxis with HTX-019 as a 30-min infusion in patients with cancer: a retrospective studyToni S Perry, Natalie Dickson, Jeffrey F Patton
Clinical Breast Cancer|March 6, 2016
Sorafenib Plus Ixabepilone as First-Line Treatment of Metastatic HER2-Negative Breast Cancer: A Sarah Cannon Research Institute Phase I/II TrialDenise A Yardley, Natalie Dickson, David Drosick, et al.
The American Journal of Managed Care|January 9, 2026
Physician-pharmacy integration in cancer care: pillars of medically integrated pharmacyGury K Doshi, Lucio Gordan, Kirollos Hanna, et al.
Journal of Clinical Pathways : the Foundation of Value-Based Care|August 28, 2019
Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment SettingCasey Mason, Peter G Ellis, Kathy Lokay, et al.
JCO Oncology Practice|July 13, 2021
Oncology Medical Home: ASCO and COA StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
Cancer|March 15, 2023
Rate of COVID-19 vaccination among patients with cancer who tested positive for severe acute respiratory syndrome-coronavirus 2: Analysis of the American Society of Clinical Oncology RegistryDax Kurbegov, Suanna S Bruinooge, Xiudong Jennifer Lei, et al.
JCO Oncology Practice|July 28, 2021
Telehealth in Oncology: ASCO Standards and Practice RecommendationsRobin T Zon, Erin B Kennedy, Kerin Adelson, et al.
JCO Global Oncology|September 30, 2020
Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global WebinarsAbdul Rahman Jazieh, Stephen L Chan, Giuseppe Curigliano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2021
Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline UpdateBeverly Moy, R Bryan Rumble, Steven E Come, et al.
Pageof 1